Sunday, May 28, 2017
 
 
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
American Academy of Ophthalmology Statement on Stem Cell Therapy for Treating Eye Disease
 
(March 20, 2017)

SAN FRANCISCO, March 20, 2017 /PRNewswire-USNewswire/ -- A recent article in the New England Journal of Medicine highlights concerns that the American Academy of Ophthalmology has previously expressed regarding stem cell therapy for diseases of the retina. 

In June 2016 the Academy issued clinical guidance that covers the appropriate use of stem cell therapy in eye care.   An article co-authored by the Academy's Chief Executive Officer in the November issue of the Academy's journal Ophthalmology highlights the dangers of unapproved trials, the need for appropriate oversight, and the risk to patients looking for a transformative cure. 


The Academy has called on both the National Institutes of Health and the U.S. Food and Drug Administration to take steps to better ensure public safety associated with treatments outside of FDA-approved clinical trials.  Good research is being performed under FDA-approved trials by innovative clinician-scientists and tragedy associated with non-approved use of stem cells threatens the conduct and impact of this high-quality science.

The public and patients can learn more about stem cells and eye care by visiting the Academy's EyeSmart® public education website. EyeSmart is the leading online source for ophthalmic information. The content is written and approved by Academy member eye physicians and surgeons.

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/american-academy-of-ophthalmology-statement-on-stem-cell-therapy-for-treating-eye-disease-300426643.html

SOURCE American Academy of Ophthalmology

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:England, USA, Medicine, Disease, Surgery, Medication, Science, Medical, Biology, Stem Cell, Science, england,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Silver Birch of Hammond Affordable Assisted Lifestyle Community Opens Doors
  • NetDirector Enables Next-Generation Integration in Radiology with American Health Imaging
  • APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market
  • Medical Imaging Equipment Market Is Expected To Reach USD 44,887.4 Mn By 2022, Credence Research
  • Growth Opportunities in the Global Diagnostic Imaging Market, 2017-2022 - Research and Markets

    Cancer
  • Cone beam computed tomography (CBCT) Systems Market Expected to Reach $1,041 Million, Globally, by 2023 - Allied Market Research
  • Mesothelioma Compensation Center Now Urges the Family of a Person Who Recently Died From Mesothelioma Before They Could Hire a Lawyer to File a Claim to Call for Instant Help
  • Mapi Research Trust Unveils New Clinical Outcome Assessments (COA) Website for the Zarit Burden Interview (ZBI) Questionnaire
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010 - 2017: Deal trends, players, financials and forecasts
  • Artificial Intelligence Firm Set to Revolutionize Healthcare
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines